The Health Protection Agency Meningococcus and Haemophilus Forum reviewed the guidance for control measures in the UK. This review has been based on available evidence and recommendations are graded according to the level of evidence on which they are based.
The review reflects more recent data on incidence of infection, updates guidance on pre-admission management and modifies choice of antibiotics for chemoprophylaxis and considers their use during pregnancy and breastfeeding. The role of conjugate vaccines has also been reviewed. Significant changes from the 2006 document are summarised at the beginning of the document (page 4).
The objective of these guidelines is to present the rationale and recommendations for the control of meningococcal disease in the United Kingdom within one comprehensive document.
These guidelines cover:
- Pre-admission management to reduce mortality rate
- Investigation of suspected cases
- Case definitions
- Public health action after a single case
- Prophylaxis in healthcare settings
- Management of clusters
- Appendix A: Examples of drug information leaflets
- Appendix B: Example of information letter to parents after a case
- Appendix C: Examples of Patient Group Directions